Cheng Chun-Yao, Hao Wen-Rui, Liu Ju-Chi, Cheng Tzu-Hurng
Department of Ophthalmology, Cathay General Hospital, Taipei 10633, Taiwan.
Department of Medical Education, National Taiwan University Hospital, Taipei 100225, Taiwan.
World J Clin Cases. 2024 Dec 16;12(35):6764-6769. doi: 10.12998/wjcc.v12.i35.6764.
This editorial highlights the study which investigated the potential of traditional Chinese medicine (TCM) as an adjunctive therapy in oral cancer management. The study included 80 patients with oral cancer to evaluate the effects of the Tongluo Jiedu prescription on inflammatory stress markers, peripheral blood T-cell subsets, and overall immune function. The results indicated that Tongluo Jiedu substantially enhances immune function and reduces oxidative stress, thereby aiding in patient recovery and potentially minimizing treatment-related complications. This editorial discusses the broader implications of these findings for oral cancer care and emphasizes the importance of integrating TCM principles into modern oncology practices.
这篇社论重点介绍了一项研究，该研究调查了中药作为口腔癌治疗辅助疗法的潜力。该研究纳入了80例口腔癌患者，以评估通络解毒方对炎症应激标志物、外周血T细胞亚群和整体免疫功能的影响。结果表明，通络解毒方显著增强免疫功能并降低氧化应激，从而有助于患者康复，并可能将治疗相关并发症降至最低。这篇社论讨论了这些发现对口腔癌护理的更广泛影响，并强调了将中医理念融入现代肿瘤学实践的重要性。
